The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Hanover Media Strategy Limited naming John Brassil .

Filed returns
18
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2017: 1 filed returns May–Aug 2017: 2 filed returns Sep–Dec 2017: 4 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 1 filed returns Sep–Dec 2018: 1 filed returns Jan–Apr 2019: 2 filed returns May–Aug 2019: 2 filed returns Sep–Dec 2019: 2 filed returns Jan–Apr 2020: 1 filed returns 2017 2018 2019 2020
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2020 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 4 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 1 On lobbying.ie
Sep–Dec 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) 7 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 4 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 5 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 10 On lobbying.ie
Sep–Dec 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 10 On lobbying.ie
May–Aug 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 13 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) 12 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 12 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) 16 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Telehealth policy in Ireland (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 8 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 18 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Telehealth policy in Ireland (Public policy or programme) 9 On lobbying.ie
Jan–Apr 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 19 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 18 100.0%